Raloxifene (Evista) as Effective as Tamoxifen (Nolvadex) for Breast Cancer Prevention
The National Cancer Institute Study of Tamoxifen and Raloxifene (STAR) Trial has just concluded. It was one of the largest breast cancer prevention studies ever. It found that raloxifene, which is usually used for osteoporosis, is as effective as tamoxifen in preventing breast cancer in post-menopausal women who are at high risk of breast cancer. Raloxifene also had fewer side effects.
This study...